Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Zevra Therapeutics
Zevra Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Zevra Therapeutics
Stock Price
$8.3
2024-10-29
Market Capitalization
$434.6 M
2024-10-29
Zevra Therapeutics Summary
Company Summary
Overview
Zevra Therapeutics is a pharmaceutical company that specializes in drug development solutions. It focuses on developing therapies to treat rare diseases such as Niemann-Pick disease type C (NPC), idiopathic hypersomnia (IH), etc.
Type
Public
Status
Active
Founded
2006
Website
https://zevra.com/
Cybersecurity rating
Sectors
Healthcare
clinical research
drug development
pharma
therapy
Homepage
Linkedin
facebook
youtube
twitter
Table of Contents
Competitors
Competitors and Similar Companies
YSOPIA Bioscience
Healthcare - Private
EIP Pharma
Healthcare - Subsidiary
Cadrenal Therapeutics
Healthcare - Public
Molecular Partners
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top